カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腰痛治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Lower Back Pain Drug Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8513 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：62 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Lower Back Pain Drug Market 調査レポートは次の情報を含め、グローバルにおけるの腰痛治療薬市場規模と予測を収録しています。・世界の腰痛治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の腰痛治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腰痛治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「急性用治療薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腰痛治療薬のグローバル主要企業は、Pfizer、 Johnson and Johnson、 Sanofi、 Endo Pharmaceuticals、 Merck、 Dr. Reddy’s Laboratories、 Vertebral Technologies、 Medtronic、 Boston Scientific、 BioWave、 Koninklijke Philips、 Stayble Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腰痛治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腰痛治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の腰痛治療薬市場：タイプ別市場シェア、2022年
・急性用治療薬、慢性用治療薬

世界の腰痛治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の腰痛治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の腰痛治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の腰痛治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腰痛治療薬のグローバル売上、2018年-2023年
・主要企業における腰痛治療薬のグローバル売上シェア、2022年
・主要企業における腰痛治療薬のグローバル販売量、2018年-2023年
・主要企業における腰痛治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Johnson and Johnson、 Sanofi、 Endo Pharmaceuticals、 Merck、 Dr. Reddy’s Laboratories、 Vertebral Technologies、 Medtronic、 Boston Scientific、 BioWave、 Koninklijke Philips、 Stayble Therapeutics

*************************************************************

・調査・分析レポートの概要
腰痛治療薬市場の定義
市場セグメント
世界の腰痛治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腰痛治療薬市場規模
世界の腰痛治療薬市場規模：2022年 VS 2029年
世界の腰痛治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腰痛治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腰痛治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：急性用治療薬、慢性用治療薬
腰痛治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
腰痛治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別腰痛治療薬市場規模 2022年と2029年
地域別腰痛治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Johnson and Johnson、 Sanofi、 Endo Pharmaceuticals、 Merck、 Dr. Reddy’s Laboratories、 Vertebral Technologies、 Medtronic、 Boston Scientific、 BioWave、 Koninklijke Philips、 Stayble Therapeutics
...

This report aims to provide a comprehensive presentation of the global market for Lower Back Pain Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lower Back Pain Drug. This report contains market size and forecasts of Lower Back Pain Drug in global, including the following market information:
Global Lower Back Pain Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Lower Back Pain Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Acute Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lower Back Pain Drug include Pfizer, Johnson and Johnson, Sanofi, Endo Pharmaceuticals, Merck, Dr. Reddy’s Laboratories, Vertebral Technologies, Medtronic and Boston Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lower Back Pain Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lower Back Pain Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Lower Back Pain Drug Market Segment Percentages, by Type, 2022 (%)
Acute Drug
Chronic Drug
Global Lower Back Pain Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Lower Back Pain Drug Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Lower Back Pain Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Lower Back Pain Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lower Back Pain Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lower Back Pain Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson and Johnson
Sanofi
Endo Pharmaceuticals
Merck
Dr. Reddy’s Laboratories
Vertebral Technologies
Medtronic
Boston Scientific
BioWave
Koninklijke Philips
Stayble Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lower Back Pain Drug, market overview.
Chapter 2: Global Lower Back Pain Drug market size in revenue.
Chapter 3: Detailed analysis of Lower Back Pain Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lower Back Pain Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lower Back Pain Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lower Back Pain Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lower Back Pain Drug Overall Market Size
2.1 Global Lower Back Pain Drug Market Size: 2022 VS 2029
2.2 Global Lower Back Pain Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lower Back Pain Drug Players in Global Market
3.2 Top Global Lower Back Pain Drug Companies Ranked by Revenue
3.3 Global Lower Back Pain Drug Revenue by Companies
3.4 Top 3 and Top 5 Lower Back Pain Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lower Back Pain Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lower Back Pain Drug Players in Global Market
3.6.1 List of Global Tier 1 Lower Back Pain Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Lower Back Pain Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Lower Back Pain Drug Market Size Markets, 2022 & 2029
4.1.2 Acute Drug
4.1.3 Chronic Drug
4.2 By Type – Global Lower Back Pain Drug Revenue & Forecasts
4.2.1 By Type – Global Lower Back Pain Drug Revenue, 2018-2023
4.2.2 By Type – Global Lower Back Pain Drug Revenue, 2024-2029
4.2.3 By Type – Global Lower Back Pain Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lower Back Pain Drug Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application – Global Lower Back Pain Drug Revenue & Forecasts
5.2.1 By Application – Global Lower Back Pain Drug Revenue, 2018-2023
5.2.2 By Application – Global Lower Back Pain Drug Revenue, 2024-2029
5.2.3 By Application – Global Lower Back Pain Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Lower Back Pain Drug Market Size, 2022 & 2029
6.2 By Region – Global Lower Back Pain Drug Revenue & Forecasts
6.2.1 By Region – Global Lower Back Pain Drug Revenue, 2018-2023
6.2.2 By Region – Global Lower Back Pain Drug Revenue, 2024-2029
6.2.3 By Region – Global Lower Back Pain Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Lower Back Pain Drug Revenue, 2018-2029
6.3.2 US Lower Back Pain Drug Market Size, 2018-2029
6.3.3 Canada Lower Back Pain Drug Market Size, 2018-2029
6.3.4 Mexico Lower Back Pain Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Lower Back Pain Drug Revenue, 2018-2029
6.4.2 Germany Lower Back Pain Drug Market Size, 2018-2029
6.4.3 France Lower Back Pain Drug Market Size, 2018-2029
6.4.4 U.K. Lower Back Pain Drug Market Size, 2018-2029
6.4.5 Italy Lower Back Pain Drug Market Size, 2018-2029
6.4.6 Russia Lower Back Pain Drug Market Size, 2018-2029
6.4.7 Nordic Countries Lower Back Pain Drug Market Size, 2018-2029
6.4.8 Benelux Lower Back Pain Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Lower Back Pain Drug Revenue, 2018-2029
6.5.2 China Lower Back Pain Drug Market Size, 2018-2029
6.5.3 Japan Lower Back Pain Drug Market Size, 2018-2029
6.5.4 South Korea Lower Back Pain Drug Market Size, 2018-2029
6.5.5 Southeast Asia Lower Back Pain Drug Market Size, 2018-2029
6.5.6 India Lower Back Pain Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Lower Back Pain Drug Revenue, 2018-2029
6.6.2 Brazil Lower Back Pain Drug Market Size, 2018-2029
6.6.3 Argentina Lower Back Pain Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Lower Back Pain Drug Revenue, 2018-2029
6.7.2 Turkey Lower Back Pain Drug Market Size, 2018-2029
6.7.3 Israel Lower Back Pain Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Lower Back Pain Drug Market Size, 2018-2029
6.7.5 UAE Lower Back Pain Drug Market Size, 2018-2029
7 Lower Back Pain Drug Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Lower Back Pain Drug Major Product Offerings
7.1.4 Pfizer Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Company Summary
7.2.2 Johnson and Johnson Business Overview
7.2.3 Johnson and Johnson Lower Back Pain Drug Major Product Offerings
7.2.4 Johnson and Johnson Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.2.5 Johnson and Johnson Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Lower Back Pain Drug Major Product Offerings
7.3.4 Sanofi Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Endo Pharmaceuticals
7.4.1 Endo Pharmaceuticals Company Summary
7.4.2 Endo Pharmaceuticals Business Overview
7.4.3 Endo Pharmaceuticals Lower Back Pain Drug Major Product Offerings
7.4.4 Endo Pharmaceuticals Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.4.5 Endo Pharmaceuticals Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Lower Back Pain Drug Major Product Offerings
7.5.4 Merck Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Dr. Reddy’s Laboratories
7.6.1 Dr. Reddy’s Laboratories Company Summary
7.6.2 Dr. Reddy’s Laboratories Business Overview
7.6.3 Dr. Reddy’s Laboratories Lower Back Pain Drug Major Product Offerings
7.6.4 Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.6.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.7 Vertebral Technologies
7.7.1 Vertebral Technologies Company Summary
7.7.2 Vertebral Technologies Business Overview
7.7.3 Vertebral Technologies Lower Back Pain Drug Major Product Offerings
7.7.4 Vertebral Technologies Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.7.5 Vertebral Technologies Key News & Latest Developments
7.8 Medtronic
7.8.1 Medtronic Company Summary
7.8.2 Medtronic Business Overview
7.8.3 Medtronic Lower Back Pain Drug Major Product Offerings
7.8.4 Medtronic Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.8.5 Medtronic Key News & Latest Developments
7.9 Boston Scientific
7.9.1 Boston Scientific Company Summary
7.9.2 Boston Scientific Business Overview
7.9.3 Boston Scientific Lower Back Pain Drug Major Product Offerings
7.9.4 Boston Scientific Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.9.5 Boston Scientific Key News & Latest Developments
7.10 BioWave
7.10.1 BioWave Company Summary
7.10.2 BioWave Business Overview
7.10.3 BioWave Lower Back Pain Drug Major Product Offerings
7.10.4 BioWave Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.10.5 BioWave Key News & Latest Developments
7.11 Koninklijke Philips
7.11.1 Koninklijke Philips Company Summary
7.11.2 Koninklijke Philips Business Overview
7.11.3 Koninklijke Philips Lower Back Pain Drug Major Product Offerings
7.11.4 Koninklijke Philips Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.11.5 Koninklijke Philips Key News & Latest Developments
7.12 Stayble Therapeutics
7.12.1 Stayble Therapeutics Company Summary
7.12.2 Stayble Therapeutics Business Overview
7.12.3 Stayble Therapeutics Lower Back Pain Drug Major Product Offerings
7.12.4 Stayble Therapeutics Lower Back Pain Drug Revenue in Global Market (2018-2023)
7.12.5 Stayble Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Lower Back Pain Drug Market Opportunities & Trends in Global Market
Table 2. Lower Back Pain Drug Market Drivers in Global Market
Table 3. Lower Back Pain Drug Market Restraints in Global Market
Table 4. Key Players of Lower Back Pain Drug in Global Market
Table 5. Top Lower Back Pain Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lower Back Pain Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lower Back Pain Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lower Back Pain Drug Product Type
Table 9. List of Global Tier 1 Lower Back Pain Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lower Back Pain Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lower Back Pain Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Lower Back Pain Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lower Back Pain Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Lower Back Pain Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Lower Back Pain Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lower Back Pain Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Lower Back Pain Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Lower Back Pain Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lower Back Pain Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Lower Back Pain Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lower Back Pain Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Lower Back Pain Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lower Back Pain Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Lower Back Pain Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lower Back Pain Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Lower Back Pain Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lower Back Pain Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Lower Back Pain Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lower Back Pain Drug Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Lower Back Pain Drug Product Offerings
Table 32. Pfizer Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson and Johnson Company Summary
Table 35. Johnson and Johnson Lower Back Pain Drug Product Offerings
Table 36. Johnson and Johnson Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson and Johnson Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Lower Back Pain Drug Product Offerings
Table 40. Sanofi Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Endo Pharmaceuticals Company Summary
Table 43. Endo Pharmaceuticals Lower Back Pain Drug Product Offerings
Table 44. Endo Pharmaceuticals Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Endo Pharmaceuticals Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Lower Back Pain Drug Product Offerings
Table 48. Merck Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Dr. Reddy’s Laboratories Company Summary
Table 51. Dr. Reddy’s Laboratories Lower Back Pain Drug Product Offerings
Table 52. Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Dr. Reddy’s Laboratories Key News & Latest Developments
Table 54. Vertebral Technologies Company Summary
Table 55. Vertebral Technologies Lower Back Pain Drug Product Offerings
Table 56. Vertebral Technologies Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Vertebral Technologies Key News & Latest Developments
Table 58. Medtronic Company Summary
Table 59. Medtronic Lower Back Pain Drug Product Offerings
Table 60. Medtronic Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Medtronic Key News & Latest Developments
Table 62. Boston Scientific Company Summary
Table 63. Boston Scientific Lower Back Pain Drug Product Offerings
Table 64. Boston Scientific Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Boston Scientific Key News & Latest Developments
Table 66. BioWave Company Summary
Table 67. BioWave Lower Back Pain Drug Product Offerings
Table 68. BioWave Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 69. BioWave Key News & Latest Developments
Table 70. Koninklijke Philips Company Summary
Table 71. Koninklijke Philips Lower Back Pain Drug Product Offerings
Table 72. Koninklijke Philips Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Koninklijke Philips Key News & Latest Developments
Table 74. Stayble Therapeutics Company Summary
Table 75. Stayble Therapeutics Lower Back Pain Drug Product Offerings
Table 76. Stayble Therapeutics Lower Back Pain Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Stayble Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Lower Back Pain Drug Segment by Type in 2022
Figure 2. Lower Back Pain Drug Segment by Application in 2022
Figure 3. Global Lower Back Pain Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lower Back Pain Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lower Back Pain Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lower Back Pain Drug Revenue in 2022
Figure 8. By Type - Global Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Lower Back Pain Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Lower Back Pain Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 16. US Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 20. Germany Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 28. China Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Lower Back Pain Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Lower Back Pain Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson and Johnson Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Endo Pharmaceuticals Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Vertebral Technologies Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Medtronic Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Boston Scientific Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. BioWave Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Koninklijke Philips Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Stayble Therapeutics Lower Back Pain Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腰痛治療薬の世界市場見通し2023年-2029年(Lower Back Pain Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

腰痛治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp